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This article investigated the impact of breast cancer (BC) in middle-aged Australian women (45–50
years). Two waves of data collected 2 years apart from a longitudinal survey of 12,177 women identified
3 groups: (a) 11,933 (98%) who reported never having had BC, (b) 181 (1.5%) who reported a diagnosis
of BC at Time 1, and (c) 63 (0.5%) who reported onset of BC between Time 1 and Time 2. Repeated
measures analysis of variance was used to compare the 3 groups. Women with recent onset of BC
experienced significant changes across a range of functioning compared with the other 2 groups.
Compared with women with no BC, women with longer established onset of BC had significantly worse
health and social outcomes, but these were associated with small effect sizes. Both groups of women with
BC reported less impact on mental and emotional health than on other areas of functioning.
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Approximately 10,000 Australian women are diagnosed with
breast cancer each year, and 1 in 12 Australian women will be
diagnosed with breast cancer by the time they are 74. Breast cancer
is the third most common cause of death among Australian women
(Australian Institute of Health and Welfare [AIHW], 1999). In-
creasing age is one risk factor for breast cancer, with the incidence
of cancer per 100,000 women at 17.8 for those aged 15–39, 146.3
for those aged 40–49, and 264.8 for those aged 50–69 (AIHW,
1999). Higher socioeconomic status (SES), family history of breast
cancer, early menarche, late menopause, lengthy exposure to post-
menopausal estrogens, childlessness, and first childbirth at a late
age are also associated with increased risk of breast cancer (Ander-
son, 1998; AIHW, 1999).
The majority of women diagnosed with breast cancer cope well
psychologically (Baker, Marcellus, Zabora, Polland, & Jodrey,
1997), with reports of a renewed vigor for life and stronger
interpersonal relationships (Petrie, Buick, Weinman, & Booth,
1999). Whereas myocardial infarction patients report beneficial
changes in terms of healthy lifestyle change, women with breast
cancer are more likely to report improved close relationships and
improved empathy with others, and both groups report greater
appreciation of health and life and a change in personal life
priorities (Petrie et al., 1999).
However, negative psychosocial consequences have also been
identified. Dimensions of life commonly negatively affected in-
clude physical, psychological and emotional, vocational, and so-
cial issues affecting intimacy with spouse, family, and friends
(Feigen et al., 2000). Treatment of breast cancer necessarily affects
physical well-being, as it typically involves surgical removal of the
tumor (involving either lumpectomy or mastectomy) and lymph
nodes, followed by chemotherapy and/or hormonal therapy, with
or without radiotherapy (Anderson, 1998). The effects of treatment
can lead to premature menopause, sexual dysfunction, loss of
fertility, pain, fatigue, and lymphedema (National Health and
Medical Research Council [NHMRC], 2000). Greater levels of
physical impairment have been associated with greater levels of
distress in early stage cancers (Manne, Glassman, & Du Hamel,
2001). While treatment can prove curative for 66% of women
(AIHW, 1999), it will only prolong survival for others who expe-
rience increased disease spread and undergo further palliative
treatment to reduce disease activity and symptoms. It can be
expected that there will be a difference in the impact of early stage
versus late stage disease, not only physically, but also
psychologically.
The psychological and emotional consequences of breast cancer
have received considerable attention in the literature, especially
with regard to increased levels of depression (NHMRC, 2000;
Shapiro et al., 2001). Between 5% and 20% of women with breast
cancer experience major depression 12–24 months postdiagnosis
(Hughson, Cooper, McArdle, & Smith, 1988). In addition, be-
tween 25% and 33% of women report moderate stress and adjust-
ment problems (Kissane et al., 1998), with younger women being
more likely to experience traumatic stress symptoms (Koopman et
al., 2002). Almost 2 years after breast cancer diagnosis, 16% of
women continue to report a high level of psychological distress
(Bleiker, Pouwer, van der Ploeg, Leer, & Ader, 2000).
Vocational issues arise for women with breast cancer because of
the disruption of work, and consequent financial problems have
also been identified as issues (NHMRC, 2000). In addition, social
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networks can be affected. The demands and consequences of
breast cancer can place stress on marriage or significant relation-
ships and are associated with communication and sexual problems
(Shapiro et al., 2001). Emotional distress after breast cancer can
lead to an erosion of social support (Alferi, Carver, Antoni, Weiss,
& Duran, 2001).
Follow up of women at 3 and 12 months after surgery for early
stage breast cancer showed that quality of life improved over time,
with improvements in functioning in the sexual, social, and emo-
tional arenas (King, Shiell, Hall, & Boyages, 2000). However,
there was no improvement in physical function or menopausal
symptoms. Younger women, single women, and those with less
education tended to fare worse on a number of indicators. Al-
though there has been an increase in longitudinal research exam-
ining the course of adjustment after breast cancer in recent years,
it has been recognized that there is still insufficient longitudinal
research that examines the impact of breast cancer and the long-
term course of adjustment after breast cancer, especially in the
context of examining the relative impact on multiple domains
(NHMRC, 2000).
The purpose of the current report is therefore to investigate the
impact of breast cancer on physical, mental, and social functioning
in a large, population-based, longitudinal survey of Australian
women. These women, aged 45–50 years when first surveyed in
1996, were followed up 2 years later. Three nonoverlapping
groups were identified: those women who reported having had
breast cancer at Time 1 (T1), those women who reported devel-
oping breast cancer between T1 and T2, and those who reported no
breast cancer at T1 or T2. Thus, a further focus of the current
report is to investigate the differential impact of breast cancer on
women who have been living with the diagnosis for a few years
and those who have been more recently diagnosed.
Method
Overview
The Australian Longitudinal Study of Women’s Health, a longitudinal
survey of the health and well-being of three cohorts of Australian women,
has been described in detail elsewhere (Brown et al., 1998; Lee, 2001). The
project uses mailed surveys to collect self-report data on health and related
variables from three cohorts of Australian women, who were aged 18–23
years, 45–50 years, and 70–75 years when the project began in 1996. The
project is designed to run for 20 years, with the overall goal of conducting
a series of interlocking data analyses that would aid in developing an
understanding of factors that affect the health and well-being of women, in
order to inform Australian government health policy (Lee, 2001).
Over 40,000 women across the three age groups were recruited on a
random basis from the Australian population, with the Australian compre-
hensive national health insurance database (Medicare) as the sampling
frame and with systematic oversampling of women living in rural and
remote areas. Privacy legislation required that the initial approach to these
women be undertaken by Medicare and that the research team not attempt
to contact nonrespondents. Initial response rate for the middle-aged groups
was 54%, and comparisons with national census data for the same year
indicated that they were demographically representative of Australian
women in that age group, with a slight bias toward higher SES (Brown et
al., 1998).
Participants
Women in the 45–50 cohort were the focus of the current study. This
group of women is of interest as they are seven times more likely to
develop breast cancer than the younger group, and yet are relatively young
and can therefore be expected to suffer more adverse impact with respect
to their physical, mental, and social functioning than older women. At T1,
14,200 women participated in Survey 1, a self-report questionnaire ad-
dressing a range of social and environmental aspects of the women’s lives,
as well as issues related to health and health service use. A second survey
was sent to these women, then aged 47–52, in 1998. The response rate at
T2 was 92%. The University of Newcastle Human Research Ethics Com-
mittee approved all aspects of the study.
Of the 14,015 women at T1 who answered the question “Have you ever
been told by a doctor that you have breast cancer?” 13,726 (97.9%) replied
in the negative and 289 (2.1%) answered in the affirmative. Those women
who did not reply to this question were not included in the study. When this
same question was asked at T2, 12,338 women answered it. Of these,
12,059 (97.7%) answered “never,” 82 (0.7%) reported onset of breast
cancer in the last 2-year period, 192 (1.6%) reported having had breast
cancer more than 2 years ago, and 5 had breast cancer both more than 2
years ago and within the last 2-year period. This latter group of women was
removed from the analysis. Three nonoverlapping groups were identified.
First, noncases included women who reported never having had breast
cancer at both T1 and T2 (n  11,933; 98%). Second, existing cases were
those women who reported having breast cancer at T1 and having had
breast cancer more than 2 years ago at T2 (N  181; 1.5%). Third, new
cases included those women who reported at T1 never having had breast
cancer but at T2 reported breast cancer being diagnosed in the last 2 years
(n  63; 0.5%). As there was no information about time since diagnosis,
disease stage, and timing of treatment, it should be recognized that there
will be a mix of these variables within each identified breast cancer group.
Measures
SES. On the basis of recommendations for the measurement of SES for
this age group (Mishra, Ball, Dobson, Byles, & Warner-Smith, 2001), a
principal components factor analysis of T1 data, including employment
status, hours worked per week, language spoken at home, ability to speak
English, time lived in Australia, and occupation (partner and self), was
carried out. After direct oblimin rotation, three factors were identified,
accounting for 59% of the variance. The first factor contained language
spoken at home, ability to speak English, and time lived in Australia. The
second factor contained employment status and hours worked, and the third
factor contained the items pertaining to occupation. Factor scores of these
three factors were added together to form an SES indicator.
The following measures were collected at both T1 and T2, representing
six domains of functioning. Measures were selected in an effort to maxi-
mize both validity and brevity; in cases where brief, valid scales were not
available, measures were developed for the purposes of the study.
Medical outcomes. The eight subscales of the Medical Outcomes
Study 36-item Short-Form Health Survey (Ware & Sherbourne, 1992) were
used: Physical Functioning, Role–Physical, Bodily Pain, General Health,
Vitality, Social Functioning, Role–Emotional and Mental Health. Higher
scores indicated better health.
Health service use. Questions relating to health service use in the last
12 months were modified from questions used by the Australian Bureau of
Statistics (1991). Five questions were contained in this section, assessing
number of visits to the family doctor, a hospital doctor, a specialist doctor,
an allied health professional, and an alternative health practitioner. Each
answer was scored on a 5-point scale ranging from none to seven or more
times, with a higher score indicating higher use of health services. The
items were added together, and the mean item score was used in analyses.
Medications. This question was devised for the purpose of the current
study and asked, “During the past 4 weeks have you taken any medications
(a) for your nerves, (b) to help you sleep, (c) for any chronic condition?”
The answer category was “no” (coded 0) or “yes” (coded 1). The mean
item score was used in analyses.
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Stress. This 9-item scale assessed the degree of stress attached to nine
specific areas (e.g., health, relationships) in the last 12 months. The 6-point
response scale included the following categories: not applicable (0), not at
all stressed (0), somewhat stressed (1), moderately stressed (2), very
stressed (3), and extremely stressed (4); a higher score indicated higher
levels of stress. Reliability and validity of this scale have been established
(Bell & Lee, 2002, 2003). The mean item score was used in analyses.
Life events. The 28 items in this section assessed the presence (coded
1) or absence (coded 0) of life events in the last 12 months (Norbeck,
1984). Two life events were removed from the list as they were indicative
of breast cancer status: experience of major personal illness and major
surgery. Life events were added together to form one score for analysis.
Life dissatisfaction. Because of the difficulty of locating an existing
measure of life satisfaction that was appropriate for this study, five items
were specifically designed. These assessed degree of satisfaction with five
areas: work/career/study, family relationships, partner relationship, friend-
ships, and social activities. The answers were recorded on a 4-point scale
ranging from very satisfied to very dissatisfied; higher scores indicated
higher levels of dissatisfaction. The mean item score for the whole scale
was used in the analyses.
The following measures were only collected at T2 and were therefore
used only in the cross-sectional analyses with Survey 2 data.
Social support. The 19-item Medical Outcomes Study Social Support
Survey (Sherbourne & Stewart, 1991) was used to assess social support,
with a stem question that asks, “How often is each of the following kinds
of support available to you if you need it?” Each item was answered on a
5-point scale, ranging from none of the time to all of the time, with higher
scores indicating greater levels of social support.
Depression. Depression was assessed with a 10-item version (Andre-
sen, Carter, Malmgren, & Patrick, 1994) of the Center for Epidemiological
Studies—Depression Scale (Radloff, 1977). Each item assessed how often
the respondent felt depressed over the past week, on a 4-point scale ranging
from rarely to most of the time. Items were summed to form a total score,
and higher scores indicated a greater level of depressive symptoms.
Design and Statistical Analyses
The main analyses were repeated measures analysis of variance, for
which the between-subjects variable was group membership (existing
cases, new cases, or noncases) and the within-subjects variable was time
(T1 and T2). In the case of the medical outcome variables, significant main
effects for group or time or for interactions were adjusted for multiple
testing ( p  .006). Post hoc analyses of differences between the three
groups used Bonferroni-adjusted alphas. The effect sizes (d) of group
differences were examined by using the difference between the mean T2
scores divided by the standard deviation of the noncases group. Effect sizes
of 0.2 are considered to be small, 0.5 moderate, and 0.8 large. Post hoc
within group differences over time were tested with paired-samples t tests.
Simple comparisons between existing cases and noncases were carried
out by means of logistic regressions, reporting odds ratios (OR) and 95%
confidence intervals (CI). Generalized linear modeling was used to com-
pare outcomes at T2 for the new cases and noncases, with the correspond-
ing T1 variable as the covariate (analysis of covariance).
Results
Validation of Breast Cancer Status
Given the reliance on self-report of breast cancer status, other
variables that might indicate the validity of the breast cancer status
were examined. Of women who reported having developed breast
cancer in the last 2 years, 36.5% also reported having had a
mastectomy in the last 2 years, and 62% reported having a lumpec-
tomy in the last 2 years; the remaining women did not specify the
procedure. Of the women who reported having breast cancer at T1,
54.7% reported having had a mastectomy over 2 years ago and
55.2% reported having had a lumpectomy over 2 years ago. Some
women had had both procedures.
At T1, existing cases were 6 times more likely than noncases to
report a major personal illness in the previous 12 months (OR 
6.55, 95% CI: 4.82–8.91), but there was no significant difference
between the two groups at T2. Compared with noncases, existing
cases were significantly more likely to report major surgery in the
previous 12 months at both T1 and T2, with odds ratios of 7.13
(95% CI: 5.17–9.84) and 2.38 (95% CI: 1.48–3.81), respectively.
Existing cases were also more likely than noncases to report
symptoms consistent with menopause at both T1 and T2, with
significantly lower occurrence of premenstrual tension (OR 
0.62, 95% CI: 0.53–0.73; and OR  0.62, 95% CI: 0.51–0.75),
and higher occurrence of both hot flashes (OR  1.45, 95% CI:
1.28–1.65; and OR  1.37, 95% CI: 1.20–1.56) and night sweats
(OR  1.45, 95% CI: 1.28–1.65; and OR  1.30, 95% CI:
1.14–1.48).
Compared with noncases, new cases reported no increased like-
lihood of experiencing a major personal illness at T1 but did report
higher occurrence of this event at T2 (OR  2.15, 95% CI:
1.02–4.52). They were also more likely to report major surgery at
T2 (OR  24.30, 95% CI: 14.53–40.63). New cases reported
being significantly more likely than noncases to experience meno-
pausal symptoms at T2, including irregular monthly periods, hot
flashes, and night sweats (all ps  .001).
SES
SES did not have a significant relationship with breast cancer
status at T1, t(7979)  0.02, p  .99, nor was it associated with
breast cancer status for women who developed breast cancer
between T1 and T2, t(7908)  0.60, p  .55. SES was therefore
not investigated in further analyses.
Differences Between and Within Groups
All results from the repeated measures analyses of variance are
summarized in Table 1. With respect to medical outcomes, women
who had developed breast cancer between T1 and T2 had signif-
icantly worse outcomes than the noncases with respect to Bodily
Pain, General Health, Mental Health, Physical Functioning, Role–
Physical, and Social Functioning. In addition, these women had a
significantly worse outcome with respect to Bodily Pain than the
existing cases, but there was no difference between these two
groups on the measures relating to General Health, Physical Func-
tioning, Role–Physical, and Social Functioning. On all of these
measures, existing cases reported significantly worse outcomes
than the noncases.
Women who had breast cancer had significantly higher usage of
health services than the women without breast cancer, even though
existing cases had decreased their use of health services between
T1 and T2. Post hoc analyses of T2 data indicated that both groups
of women with breast cancer had significantly more consultations
with hospital doctors and medical specialists than noncases. New
cases also had more appointments with the family doctor, whereas
existing cases had 1.18 (95% CI: 1.05–1.33) times more appoint-
ments with alternative health practitioners.
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Although all three groups of women reported some increase in
medication use over the 2-year period, medication use was signif-
icantly higher for the women who had breast cancer than for the
noncases, and the new cases experienced a large increase in
medication use. Post hoc analyses of T2 data indicated that exist-
ing cases were 1.6 (95% CI: 1.00–2.57) times more likely to use
medications for sleep, and that new cases used significantly more
medication for both sleep ( p  .001) and nerves ( p  .001).
Stress was significantly higher for the new cases compared with
the noncases, with only a small increase in stress for the new cases.
Post hoc analysis of covariance analyses indicated that the stress
for the new cases was related to health (d  1.50, p  .0005), and
money (d  0.41, p  .0005). Women who had developed breast
cancer between T1 and T2 had decreased their hours of paid
employment over this time, t(55)  1.92, p  .06.
Life events decreased from T1 to T2 for all women. Post hoc
analyses showed that women who had developed breast cancer
before T1 were more likely to report being forced into unwanted
sexual activity than the women without breast cancer (OR  2.81,
95% CI: 1.36–5.79). Both groups of women with breast cancer
were more likely to experience menopause than were the other
women.
Finally, there were no significant differences between the
groups with respect to life dissatisfaction. Post hoc analyses sug-
gested that existing cases experienced greater dissatisfaction with
their partner at T1 than noncases, and that new cases experienced
greater satisfaction at T2 with friendships and social activities than
noncases.
T2 Measures
While longitudinal analyses could not be used with the social
support and depression measures, cross-sectional analyses showed
that there were no significant differences between the noncases
and new cases with respect to perceived social support. Women
with breast cancer scored marginally higher on the Center for
Epidemiological Studies—Depression Scale, with an OR of 1.05
(95% CI: 1.01–1.09).
Discussion
The current study investigated the impact of breast cancer across
multiple dimensions of functioning in a large population of
middle-aged Australian women. Given that a major weakness of
the current study is reliance on a single self-report item in the
context of a comprehensive health survey to diagnose the absence
or presence of breast cancer, it is important to examine the validity
of the breast cancer diagnosis. One such indicator of validity is that
Table 1
Mixed Between–Within Analysis of Variance Examining Mean (SD) Change in Continuous Independent Variables Over Time, and
Effect Size (d), Across the Three Study Cohorts
Variable
Never had BC BC before Time 1 only
BC developed between Time 1 and
Time 2
Time 1 Time 2 M  (SD) d Time 1 Time 2 M  (SD) d Time 1 Time 2 M  (SD) d
Medical outcomes
Bodily paina,b,c 71.34 71.09a 0.25 0.01 70.51 68.37a 2.14 0.08 66.43 55.67b 10.76 0.41
(23.32) (24.00) (22.89) (25.73) (26.00) (26.10) (27.14) (29.63) (26.11)
General healtha,b,c 72.90 73.21a 0.30 0.02 65.52 67.87b 2.36 0.13 71.48 60.18b 11.31 0.55
(19.95) (20.13) (15.20) (21.84) (22.30) (17.68) (18.81) (24.22) (20.49)
Mental healthb 73.52 73.89a 0.36 0.02 71.06 70.82 0.24 0.01 70.21 67.56b 2.65 0.15
(17.47) (18.37) (16.39) (17.61) (17.62) (17.50) (19.82) (22.49) (17.69)
Physical functioninga,b 86.09 84.15a 1.94 0.12 82.98 80.87b 2.10 0.10 83.38 75.42b 7.95 0.45
(17.62) (18.79) (16.32) (19.26) (19.86) (20.21) (21.76) (21.61) (17.64)
Role–emotional 78.73 80.04 1.31 0.03 74.58 72.60 1.98 0.04 75.13 73.54 1.59 0.04
(35.01) (34.45) (38.60) (37.27) (38.82) (48.04) (34.89) (40.23) (39.00)
Role–physicala,b,c 81.15 77.91a 3.23 0.08 71.00 72.58b 1.58 0.04 78.57 56.35b 22.22 0.47
(34.06) (35.20) (38.20) (40.85) (38.56) (44.03) (35.60) (43.06) (47.33)
Social functioningb 82.84 82.35a 0.48 0.02 78.94 78.25b 0.69 0.02 77.78 70.44b 7.34 0.28
(22.92) (23.42) (23.94) (25.60) (25.22) (28.10) (22.16) (30.23) (26.24)
Vitalitya 59.08 57.95 1.13 0.06 55.38 54.03 1.35 0.07 57.62 51.35 6.27 0.30
(20.71) (21.99) (18.67) (21.70) (22.36) (20.84) (22.56) (25.92) (21.00)
Other variables
Health service usea,b,c 1.88 1.78a 0.10 0.18 2.32 2.03b 0.29 0.40 1.91 2.76b 0.86 1.09
(0.61) (0.57) (0.56) (0.73) (0.67) (0.73) (0.63) (0.82) (0.79)
Medicationsa,b,c 0.32 0.36a 0.04 0.07 0.46 0.51b 0.05 0.07 0.36 0.68b 0.32 0.44
(0.60) (0.59) (0.57) (0.64) (0.72) (0.69) (0.69) (0.84) (0.73)
Stressb,c 0.66 0.62a 0.04 0.10 0.74 0.66 0.08 0.19 0.73 0.89b 0.16 0.28
(0.51) (0.50) (0.42) (0.51) (0.47) (0.43) (0.60) (0.63) (0.57)
Life eventsa,c 2.90 2.04 0.87 0.34 3.23 1.85 1.38 0.56 3.03 2.31 0.72 0.29
(2.30) (1.83) (2.54) (2.29) (1.63) (2.44) (2.27) (1.79) (2.53)
Life dissatisfactiona,c 3.16 3.03 0.13 0.32 3.09 2.97 0.13 0.30 3.18 3.19 0.01 0.02
(0.50) (0.49) (0.41) (0.58) (0.54) (0.44) (0.52) (0.42) (0.51)
Note. Estimated marginal means at Time 2 within the same row with different subscript letters were significantly different ( p .05), controlling for Time
1 scores (Bonferroni adjusted). BC  breast cancer.
a Significant main effect for time. b Significant main effect for group. c Significant Group  Time interaction.
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women reporting a diagnosis of breast cancer also reported in-
creased surgery in the previous 12 months, particularly specific
surgical procedures consistent with this diagnosis, namely, mas-
tectomy and lumpectomy. Women with breast cancer were also
more likely to report experiencing a health crisis in the previous 12
months. Further, they also reported being more likely to be going
through menopause, a well-recognized side effect of breast cancer
treatment, which was also associated with increased hot flashes
and night sweats.
In neither group of women with breast cancer was the diagnosis
associated with SES, as previously found in other research (Ander-
son, 1998). This is likely to reflect a difference in the significance
of SES in Australia compared with the United States or the United
Kingdom. Class differences within Australia may be smaller and
more modifiable than in some countries, partly as a result of
relatively high-quality public health and education services.
Women diagnosed with breast cancer in the 2 years prior to our
second wave of data collection (new cases) underwent many
changes relative to the other two groups of women, those with
breast cancer prior to the first wave of data collection and those
without breast cancer. They experienced significant increases in
bodily pain, and decreases in general health and physical role, with
comparative effect sizes in the moderate range from 0.41 to 0.55.
In addition, these women experienced increased levels of health
service use, medication use (for sleep and nerves), and stress,
relative to the other two groups of women, with the health service
change being associated with a large effect size. Apart from stress
related to health, stress related to money is of particular relevance
at this early stage, associated with a decrease in hours in paid
employment, although it may also arise from the financial burden
of health care.
Between T1 and T2, the new cases experienced significant but
small (with d 0.5) decreases in vitality and physical functioning.
At T2, compared with the noncases, the new cases experienced
significantly lower levels of mental health, though the effect size
is small (0.34), as well as moderately significantly lower levels of
social functioning (d  0.51). Unlike the other two groups of
women, who experienced significantly decreased dissatisfaction
with their lives, the new cases experienced no change in satisfac-
tion. Consistent with previous findings (Petrie et al., 1999), how-
ever, these women did report greater satisfaction with friendships
and social activities than the women without breast cancer. After
diagnosis with breast cancer, mental health was significantly worse
and depression was significantly higher for the new cases than for
noncases. In both cases, the effect sizes for these differences are
small. Social functioning at T2 for new cases was also significantly
worse than for noncases, with a moderate effect size. In summary,
these women experienced a number of adverse consequences
across a variety of life domains.
The existing cases showed no significant differences from non-
cases with respect to bodily pain, mental health, emotional role,
vitality, stress, or life dissatisfaction. Indeed, these women expe-
rienced a significant improvement with life satisfaction over time.
However, women who have had breast cancer for at least 2 years
continued to experience significantly lower general health, phys-
ical functioning, and role–physical and social functioning than
women without breast cancer. While the effect sizes of these
differences are small, ranging from 0.15 to 0.26, indicating that
adjustment after breast cancer is a long-term process, these effect
sizes are relatively small compared with those experienced by the
new cases, suggesting that improvement was occurring over time.
With respect to social functioning it is of particular concern that,
at the first survey, these women experienced lower levels of
satisfaction with partners, perhaps associated with the finding that
a sizable minority also reported being forced to take part in
unwanted sexual activity. Sexual dysfunction can continue up to 2
years postsurgery (NHMRC, 2000), but partners may assume that
life will return to normal once active treatment is over, and become
impatient with continuing sexual problems. Partners of women
with breast cancer may require further support or information than
they currently typically receive, in order that they can offer better
support to their partner over a long-term course.
These women who had been living with breast cancer for longer
also reported using more medications for sleep than noncases, and
also significantly greater use of health services. At Time 2 these
women were more likely to be seeing alternative health practitio-
ners such as a chiropractor, naturopath, acupuncturist, or herbalist.
This may indicate some anxiety in remaining well, and searching
for options to increase the chances of doing so. It may also reflect
an increased dissatisfaction with the traditional Western medical
care that was available to them once active treatment was
completed.
There is some indication of mental health being impacted, but
mental health appears to be more robust (less impacted by breast
cancer) than other areas of functioning such as physical and social
functioning. new cases report higher levels of depression than
noncases, albeit a weak cross-sectional relationship. Mental health
is significantly poorer for new cases than noncases, but this effect
size (0.34) is far smaller than those for other domains of
functioning.
The limitations of this study center mainly on the self-report
nature of the breast cancer diagnosis. Given that reporting of life
events retrospectively is associated with some degree of error
(Henry, Moffitt, Caspi, Langley, & Silva, 1994), there are likely to
be some false positive or false negative cases identified in our
current sample. This effect was countered somewhat by using both
T1 and Time 2 reports to cross-check the reliability of the reports
in the current data set. Because breast cancer was only one of a
large number of health-related variables assessed in a comprehen-
sive survey, and because the survey was designed for an entire
population, most of whom had never had breast cancer, informa-
tion with respect to tumor grades and cancer stage, and details
pertaining to treatment, were not obtained. Therefore, we have no
way of examining the differential impact of early and late stage
breast cancer within each group of women with breast cancer.
Results should also be interpreted with an emphasis on the effect
sizes rather than statistical significance. In some cases, particularly
with respect to changes over time for the large number of non-
cases, small effect sizes are statistically significant but not clini-
cally significant. Whereas the differences between the existing
cases and noncases generally had small effect sizes, differences in
the Medical Outcomes Study 36-item Short-Form Health Survey
subscales (Ware & Sherbourne, 1992) are equivalent to those
found in a British study that compared community-living individ-
uals with major chronic diseases and those without (Jenkinson,
Coulter, & Wright, 1993). The changes experienced in time by the
new cases are typically associated with moderate to large effect
sizes (0.51 to 1.72) and therefore are not trivial.
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The results of this study are consistent with previous literature
that suggests that breast cancer can severely impact on a variety of
domains, including health, social, mental, vocational, financial,
and spousal intimacy (Feigen et al., 2000). It is heartening to note
that, over time, women with breast cancer are less likely to be
differentiated from women without breast cancer in terms of health
indicators. However, at least 2 years after the diagnosis and med-
ical treatment of breast cancer, the women continue to experience
poorer functioning with respect to general health, physical func-
tioning, and social functioning. Further attention needs to be paid
to these areas of functioning once active medical treatment for
breast cancer ceases, and issues concerning ongoing long-term
functioning need to be addressed.
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